MIRA Pharmaceuticals, Inc. Share Price
MIRAMIRA Pharmaceuticals, Inc. Stock Performance
Open $1.02 | Prev. Close $1.07 | Circuit Range N/A |
Day Range $1.02 - $1.03 | Year Range $0.73 - $2.44 | Volume 1,562 |
Average Traded $1.03 |
MIRA Pharmaceuticals, Inc. Share Price Chart
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
MIRA Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Apr-26 | $1.08 | $1.07 | -4.02% |
02-Apr-26 | $1.10 | $1.12 | +2.75% |
01-Apr-26 | $1.10 | $1.09 | +2.83% |
31-Mar-26 | $1.06 | $1.06 | +1.92% |
27-Mar-26 | $1.00 | $1.04 | -0.95% |
26-Mar-26 | $1.11 | $1.05 | -7.08% |
25-Mar-26 | $1.13 | $1.13 | +7.62% |